Management of Acute Ischemic Stroke
Administer IV alteplase (0.9 mg/kg, maximum 90 mg) to eligible patients within 3 hours of symptom onset, with a target door-to-needle time under 60 minutes, and consider endovascular thrombectomy for large vessel occlusions within 6-24 hours based on imaging selection. 1, 2, 3
Pre-Hospital Recognition and Transport
- EMS should use FAST (Face, Arms, Speech, Time) screening tools to rapidly identify stroke patients, as even a single abnormality has 72% probability of stroke 2, 3
- Pre-notify the receiving hospital immediately to activate stroke protocols and prepare the stroke team, imaging, and necessary resources before patient arrival 2, 3
- Document the exact time the patient was last known to be normal (last known well time), as this determines treatment eligibility, not when symptoms were discovered 1, 3
- Transport directly to comprehensive stroke centers capable of endovascular therapy when large vessel occlusion is suspected, rather than routing through primary stroke centers ("mothership" approach preferred over "drip-and-ship" when feasible) 1
Emergency Department Assessment (Target: Door-to-Imaging <25 minutes)
- Perform immediate non-contrast CT scan to rule out hemorrhage and identify early infarction signs 1, 2, 3
- Complete CT angiography immediately to identify large vessel occlusions and their location 2, 3
- Assess NIHSS score during parallel processing while imaging is being obtained 1
- Obtain essential labs: CBC, PT/INR, aPTT, glucose, electrolytes, renal function (but do not delay treatment waiting for results unless anticoagulation use is suspected) 1, 2
IV Alteplase Administration (0-3 Hours Window)
Inclusion criteria 1:
- Clearly defined symptom onset within 3 hours
- Measurable neurologic deficit on NIHSS
- Age ≥18 years
- CT scan showing no hemorrhage
Critical exclusion criteria 1:
- Blood pressure >185/110 mmHg (must lower before treatment)
- Platelet count <100,000
- INR >1.6 or PT >15 seconds
- Glucose <50 or >400 mg/dL
- Prior stroke or serious head injury within 3 months
- Major surgery within 14 days
- History of intracranial hemorrhage
- Rapidly improving or minor symptoms
- 0.9 mg/kg (maximum 90 mg total)
- Give 10% as IV bolus over 1 minute
- Infuse remaining 90% over 60 minutes
- Administer directly in CT room after excluding hemorrhage to minimize door-to-needle time 1
Extended Window Alteplase (3-4.5 Hours)
Additional exclusion criteria beyond standard 0-3 hour criteria 1:
- Age >80 years
- NIHSS >25
- Combination of prior stroke AND diabetes
- ANY oral anticoagulant use (regardless of INR)
Note: The 3-4.5 hour window shows more modest benefits with higher comorbidity patients excluded 1. For wake-up strokes with unknown onset time, alteplase may be considered if DWI/FLAIR mismatch is present on MRI 1.
Blood Pressure Management
Before alteplase administration 1, 3:
- Must achieve BP <185/110 mmHg before giving alteplase
- Use labetalol, nicardipine, or clevidipine to lower BP if needed
During and after alteplase (first 24 hours) 1, 3:
- Maintain BP ≤180/105 mmHg
- Monitor BP every 15 minutes during infusion and for 2 hours after
- Then every 30 minutes for 6 hours
- Then hourly until 24 hours
For patients NOT receiving alteplase 2:
- Avoid treating hypertension unless systolic BP >220 mmHg or diastolic BP >120 mmHg
- Permissive hypertension supports cerebral perfusion in acute phase
Endovascular Thrombectomy (EVT)
- Proximal anterior circulation large vessel occlusion (ICA, M1, proximal M2)
- Standard window: within 6 hours of symptom onset
- Extended window: up to 24 hours in selected patients with favorable CT perfusion or MRI diffusion/perfusion mismatch
Optimal technique (BADDASS approach) 1:
- Use combined stent-retriever and aspiration technique
- Deploy stent-retriever with two-thirds beyond thrombus
- Apply dual aspiration through balloon guide catheter and distal access catheter during retrieval
- Goal: first-pass complete reperfusion to minimize time-dependent injury
System considerations 1:
- Activate neuro-interventional team in parallel with stroke team at CT scanner
- Have standardized angiography tray (Brisk Recanalization Ischemic Stroke Kit) ready
- Consider tenecteplase over alteplase for patients undergoing EVT (improved fibrin-specificity, longer half-life, single bolus administration) 1
Post-Alteplase Monitoring and Complications
- Assess every 15 minutes during and for 2 hours after infusion
- Every 30 minutes for next 6 hours
- Hourly until 24 hours
- If severe headache, acute hypertension, nausea, vomiting, or neurological worsening occurs: stop infusion immediately and obtain emergency head CT 1
Symptomatic intracranial hemorrhage management 1, 3:
- Stop alteplase infusion
- Obtain emergent non-contrast head CT
- Check CBC, PT/INR, aPTT, fibrinogen, type and cross-match
- Administer cryoprecipitate 10 units over 10-30 minutes (additional dose if fibrinogen <200 mg/dL)
- Give tranexamic acid 1000 mg IV over 10 minutes OR ε-aminocaproic acid 4-5 g over 1 hour
- Consult hematology and neurosurgery
- Discontinue alteplase and hold ACE inhibitors
- Maintain airway (awake fiberoptic intubation if needed)
- Give IV methylprednisolone 125 mg
- Give IV diphenhydramine 50 mg
- Give ranitidine 50 mg IV or famotidine
Physiological Parameter Management
- Monitor temperature every 4 hours for first 48 hours
- Treat fever >37.5°C with antipyretics (acetaminophen)
- Identify and treat sources of hyperthermia (infections)
- Hypothermia only in clinical trial context
- Monitor blood glucose regularly
- Treat hyperglycemia to maintain 140-180 mg/dL
- Avoid hypoglycemia with close monitoring
Avoid routine interventions 1:
- Delay nasogastric tubes, indwelling bladder catheters, or intra-arterial pressure catheters for 24 hours if patient can be safely managed without them
Early Antiplatelet Therapy
- Start aspirin 160-325 mg within 24-48 hours after ruling out hemorrhage on follow-up imaging 2, 3, 4
- If alteplase was given, wait 24 hours before starting aspirin 3
- Do NOT use urgent anticoagulation (IV heparin) for unselected acute ischemic stroke patients—hemorrhage risks exceed benefits 3, 4
Stroke Unit Care and Early Rehabilitation
- Admit all stroke patients to a geographically defined stroke unit with specialized staff within 24 hours of arrival (reduces mortality OR 0.76 and dependency OR 0.80) 2
- Begin rehabilitation assessment within 48 hours of admission 2
- Start frequent, brief out-of-bed activity (active sitting, standing, walking) within 24 hours if no contraindications 2
- Screen swallowing, nutrition, and hydration status on day of admission; provide alternative feeding (NG, ND, or PEG) if unable to take oral intake safely 2
Management of Cerebral Edema and Increased ICP
- Do NOT use corticosteroids for cerebral edema 2
- Use osmotherapy and hyperventilation for deteriorating patients 2
- For large cerebellar infarctions with brainstem compression: surgical decompression may be life-saving 2
- For malignant MCA infarction: proceed urgently to decompressive hemicraniectomy before significant GCS decline or pupillary changes, ideally within 48 hours of onset 3
Seizure Management
- Treat new-onset seizures with short-acting medications (lorazepam IV) if not self-limiting 2
- Do NOT use prophylactic anticonvulsants 2
Common Pitfalls to Avoid
- Every 30-minute delay in recanalization decreases good functional outcome by 8-14%—speed is critical 2
- Do not be overly restrictive with treatment criteria—current practice often extends beyond strict guideline recommendations based on individualized risk-benefit assessment 1
- Failure to obtain follow-up imaging at 24 hours before starting antiplatelets or anticoagulants increases hemorrhage risk 1
- Inadequate blood pressure control before thrombolysis significantly increases symptomatic ICH risk 1
- Missing swallowing dysfunction leads to aspiration pneumonia—screen early 2
- Delaying rehabilitation worsens functional outcomes—begin within 24-48 hours 2